These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19341056)

  • 21. Text message reminders to promote human papillomavirus vaccination.
    Kharbanda EO; Stockwell MS; Fox HW; Andres R; Lara M; Rickert VI
    Vaccine; 2011 Mar; 29(14):2537-41. PubMed ID: 21300094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Introduction to vaccination against cervical cancer].
    de Melker HE; Conyn-van Spaendonck MA; Boot HJ; Coutinho RA
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):658-61. PubMed ID: 19425324
    [No Abstract]   [Full Text] [Related]  

  • 24. [HPV vaccination].
    Gross G
    Hautarzt; 2007 Jun; 58(6):481-2. PubMed ID: 17729430
    [No Abstract]   [Full Text] [Related]  

  • 25. The case for vaccinating boys against human papillomavirus.
    Hull SC; Caplan AL
    Public Health Genomics; 2009; 12(5-6):362-7. PubMed ID: 19684448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
    Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
    Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
    Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
    Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.
    Lévy-Bruhl D; Bousquet V; King LA; O'Flanagan D; Bacci S; Lopalco PL; Salmaso S;
    Eur J Cancer; 2009 Oct; 45(15):2709-13. PubMed ID: 19695863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human papillomavirus vaccination in Denmark].
    Svane D
    Ugeskr Laeger; 2009 Mar; 171(13):1088. PubMed ID: 19321083
    [No Abstract]   [Full Text] [Related]  

  • 30. What to do about HPV?
    Kotz D
    US News World Rep; 2007 Oct; 143(15):53. PubMed ID: 18389946
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vaccination against human papillomavirus in the Czech Republic].
    Mouková L; Feranec R; Chovanec J
    Klin Onkol; 2010; 23(2):125-6. PubMed ID: 20465093
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus vaccine should be given before sexual debut for maximum benefit.
    Hildesheim A; Herrero R
    J Infect Dis; 2007 Nov; 196(10):1431-2. PubMed ID: 18008218
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
    Callréus T; Svanström H; Nielsen NM; Poulsen S; Valentiner-Branth P; Hviid A
    Vaccine; 2009 May; 27(22):2954-8. PubMed ID: 19428906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence.
    Bonanni P; Boccalini S; Bechini A
    Vaccine; 2009 May; 27 Suppl 1():A46-53. PubMed ID: 19480962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ten years of papillomavirus vaccination: New challenges and opportunities].
    Redondo Margüello E; Bosch José X
    Semergen; 2017; 43(4):263-264. PubMed ID: 28528165
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV 18 antibody levels, clinical efficacy and induced immune memory: a trio?
    Tjalma WA; De Ridder MR
    Vaccine; 2009 Oct; 27(43):5921-2. PubMed ID: 19628059
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
    Pawlita M; Gissmann L
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which human papillomavirus vaccine and vaccination strategy for national programs?
    Lehtinen M
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1049-1050. PubMed ID: 30133692
    [No Abstract]   [Full Text] [Related]  

  • 40. [HPV and effectiveness of chlamydia control].
    Lehtinen M; Eriksson T; Apter D
    Duodecim; 2009; 125(13):1377-84. PubMed ID: 19678493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.